Aeterna Financial Statements From 2010 to 2024
| AEZSDelisted Stock | USD 6.14 0.08 1.29% |
Check Aeterna Zentaris financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aeterna Zentaris' main balance sheet or income statement drivers, such as , as well as many indicators such as . Aeterna financial statements analysis is a perfect complement when working with Aeterna Zentaris Valuation or Volatility modules.
Aeterna |
Aeterna Zentaris Company Shares Owned By Insiders Analysis
Aeterna Zentaris' Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Aeterna Zentaris Shares Owned By Insiders | 1.32 % |
Most of Aeterna Zentaris' fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aeterna Zentaris is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
CompetitionBased on the latest financial disclosure, 1.32% of Aeterna Zentaris are shares owned by insiders. This is 91.3% lower than that of the Biotechnology sector and 90.69% lower than that of the Health Care industry. The shares owned by insiders for all United States stocks is 86.92% higher than that of the company.
Aeterna Zentaris Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Aeterna Zentaris's current stock value. Our valuation model uses many indicators to compare Aeterna Zentaris value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aeterna Zentaris competition to find correlations between indicators driving Aeterna Zentaris's intrinsic value. More Info.Aeterna Zentaris is rated fourth in return on equity category among its peers. It is rated third in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Aeterna Zentaris by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Aeterna Zentaris Financial Statements
Aeterna Zentaris shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Aeterna Zentaris investors may analyze each financial statement separately, they are all interrelated. The changes in Aeterna Zentaris' assets and liabilities, for example, are also reflected in the revenues and expenses on on Aeterna Zentaris' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Aeterna Zentaris Inc. was incorporated in 1990 and is headquartered in Summerville, South Carolina. Aeterna Zentaris is traded on NASDAQ Exchange in the United States.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Consideration for investing in Aeterna Stock
If you are still planning to invest in Aeterna Zentaris check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aeterna Zentaris' history and understand the potential risks before investing.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |